Waverley Pharma Inc (WAVE) — Cash Flow-to-Debt Ratio
Waverley Pharma Inc (WAVE) has a Cash Flow-to-Debt Ratio of -0.02x as of March 2026, meaning its operating cash flow of CA$-65.14K could theoretically repay 0% of its total liabilities (CA$3.92 Million) in one year. Check cash flow reinvestment rate of Waverley Pharma Inc to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Waverley Pharma Inc Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Waverley Pharma Inc across 11 annual periods. Check WAVE cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Annual Cash Flow-to-Debt Ratio for Waverley Pharma Inc (2015–2025)
Year-by-year debt coverage analysis for Waverley Pharma Inc. For the full cash flow conversion analysis, see Waverley Pharma Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | CA$-611.03K | CA$3.82 Million | ▼ -59.2% |
| 2024 | -0.10x | CA$-410.19K | CA$4.08 Million | ▲ +79.4% |
| 2023 | -0.49x | CA$-1.02 Million | CA$2.09 Million | ▼ -229.1% |
| 2022 | -0.15x | CA$-237.06K | CA$1.60 Million | ▲ +64.8% |
| 2021 | -0.42x | CA$-798.78K | CA$1.89 Million | ▼ -68.9% |
| 2020 | -0.25x | CA$-361.70K | CA$1.45 Million | ▲ +72.6% |
| 2019 | -0.91x | CA$-1.41 Million | CA$1.55 Million | ▲ +20.6% |
| 2018 | -1.15x | CA$-1.45 Million | CA$1.26 Million | ▼ -1592.1% |
| 2017 | -0.07x | CA$-108.69K | CA$1.60 Million | ▲ +99.3% |
| 2016 | -9.27x | CA$-108.69K | CA$11.72K | ▲ +9.2% |
| 2015 | -10.21x | CA$-108.69K | CA$10.65K | — |